BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26143117)

  • 41. Toxicity of 2-deoxygalactose to Saccharomyces cerevisiae cells constitutively synthesizing galactose-metabolizing enzymes.
    Platt T
    Mol Cell Biol; 1984 May; 4(5):994-6. PubMed ID: 6328283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and molecular biology of type I galactosemia: disease-associated mutations.
    McCorvie TJ; Timson DJ
    IUBMB Life; 2011 Nov; 63(11):949-54. PubMed ID: 21960482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.
    McCorvie TJ; Kopec J; Pey AL; Fitzpatrick F; Patel D; Chalk R; Shrestha L; Yue WW
    Hum Mol Genet; 2016 Jun; 25(11):2234-2244. PubMed ID: 27005423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biochemical mechanisms of the development of hereditary galactosemia in W/SSM strain rats].
    Solov'eva NA; Salganik RI
    Genetika; 1982 Mar; 18(3):420-7. PubMed ID: 7200438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma.
    Tang M; Etokidem E; Lai K
    Anticancer Res; 2016 Dec; 36(12):6265-6271. PubMed ID: 27919945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cloning and expression of the Klebsiella pneumoniae galactose operon.
    Peng HL; Fu TF; Liu SF; Chang HY
    J Biochem; 1992 Nov; 112(5):604-8. PubMed ID: 1478918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase.
    Reichardt JK; Woo SL
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2633-7. PubMed ID: 2011574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substrate specificity and mechanism from the structure of Pyrococcus furiosus galactokinase.
    Hartley A; Glynn SE; Barynin V; Baker PJ; Sedelnikova SE; Verhees C; de Geus D; van der Oost J; Timson DJ; Reece RJ; Rice DW
    J Mol Biol; 2004 Mar; 337(2):387-98. PubMed ID: 15003454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model.
    Slepak T; Tang M; Addo F; Lai K
    Mol Genet Metab; 2005 Nov; 86(3):360-71. PubMed ID: 16169270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A yeast expression system for human galactose-1-phosphate uridylyltransferase.
    Fridovich-Keil JL; Jinks-Robertson S
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):398-402. PubMed ID: 8421669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III.
    Kumar SU; Sankar S; Kumar DT; Younes S; Younes N; Siva R; Doss CGP; Zayed H
    Cell Biochem Biophys; 2021 Jun; 79(2):201-219. PubMed ID: 33555556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The gal genes for the Leloir pathway of Lactobacillus casei 64H.
    Bettenbrock K; Alpert CA
    Appl Environ Microbiol; 1998 Jun; 64(6):2013-9. PubMed ID: 9603808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and characterization of a bifunctional fusion enzyme composed of UDP-galactose 4-epimerase and galactose-1-P uridylyltransferase.
    Tamada Y; Swanson BA; Arabshahi A; Frey PA
    Bioconjug Chem; 1994; 5(6):660-5. PubMed ID: 7873670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of five mutations in a patient with galactose metabolic disorders.
    Schulpis KH; Thodi G; Iakovou K; Dotsikas Y; Molou E; Loukas YL
    J Pediatr Endocrinol Metab; 2018 Jan; 31(2):221-222. PubMed ID: 29303783
    [No Abstract]   [Full Text] [Related]  

  • 55. An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia.
    Kumar S U; Kumar D T; R S; Doss C GP; Zayed H
    Comput Biol Med; 2020 Feb; 117():103583. PubMed ID: 32072977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment.
    Succoio M; Sacchettini R; Rossi A; Parenti G; Ruoppolo M
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AAV-mediated expression of galactose-1-phosphate uridyltransferase corrects defects of galactose metabolism in classic galactosemia patient fibroblasts.
    Brophy ML; Stansfield JC; Ahn Y; Cheng SH; Murphy JE; Bell RD
    J Inherit Metab Dis; 2022 May; 45(3):481-492. PubMed ID: 34918784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcellular localization of galactose-1-phosphate uridylyltransferase in the yeast Saccharomyces cerevisiae.
    Christacos NC; Marson MJ; Wells L; Riehman K; Fridovich-Keil JL
    Mol Genet Metab; 2000 Aug; 70(4):272-80. PubMed ID: 10993714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleotide sugar profiles throughout development in wildtype and galt knockout zebrafish.
    Haskovic M; Coelho AI; Lindhout M; Zijlstra F; Veizaj R; Vos R; Vanoevelen JM; Bierau J; Lefeber DJ; Rubio-Gozalbo ME
    J Inherit Metab Dis; 2020 Sep; 43(5):994-1001. PubMed ID: 32441338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpression and purification of the galactose operon enzymes from Escherichia coli.
    Vorgias CE; Lemaire HG; Wilson KS
    Protein Expr Purif; 1991; 2(5-6):330-8. PubMed ID: 1821806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.